`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`
`
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`ELI LILLY AND COMPANY,
`
`
`Defendant.
`
`
`
`
`
`
`JOINT MOTION AND STIPULATION REGARDING ENTRY OF JUDGMENT AND
`POST-TRIAL BRIEFING
`
`Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc.
`
`have agreed to enter into this joint motion and stipulation to streamline the post-trial briefing
`
`process for the parties and the Court;
`
`WHEREAS, the jury in this case returned a verdict in favor of Teva on November 9, 2022;
`
`WHEREAS, the Parties wish to file certain post-trial motions; and
`
`WHEREAS, the Parties have agreed to a proposed judgment for review by the Court;
`
`NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and between
`
`the Parties hereto, and subject to leave granted by the Court, as follows:
`
`1.
`
`The Parties propose that the Court enter a judgment in the form of the jointly agreed
`
`draft attached to this stipulation as Exhibit A on December 30, 2022.
`
`
`
`Case 1:18-cv-12029-ADB Document 637 Filed 12/30/22 Page 2 of 5
`
`2.
`
`In accordance with the Federal Rules, any motion by Lilly pursuant to Fed. R. Civ.
`
`P. 50(b) and/or 59, shall be filed within 28 days of entry of judgment. Any motion by Teva relating
`
`to equitable relief and damages shall also be due twenty-eight (28) days after the entry of judgment.
`
`3.
`
`4.
`
`The parties agree to file all motions identified in ¶ 2 on January 27, 2023.
`
`The parties jointly request that the Court grant leave for each party to file a single
`
`opening brief of 30 pages, excluding any accompanying cover motions, exhibits, or declarations.
`
`5.
`
`All oppositions to any motions filed pursuant to ¶ 2 shall be due on February 24,
`
`2023.
`
`6.
`
`The parties jointly request that the Court grant leave for each party to file an
`
`opposition brief of 30 pages, excluding any accompanying cover motions, exhibits, or declarations.
`
`7.
`
`Any replies to any oppositions filed pursuant to ¶ 5 shall be due on March 10,
`
`2023.
`
`8.
`
`The parties jointly request that the Court grant leave for each party to file a reply
`
`brief of 15 pages, excluding any accompanying cover motions, exhibits, or declarations.
`
`9.
`
`To the extent the Court enters judgment after December 30, 2022, the parties agree
`
`that the post-trial briefing deadlines set forth above in Paragraphs 3, 5, and 7 shall remain in effect.
`
`IT IS SO ORDERED:
`
`Dated:
`
`12/30/2022
`
`Hon. Allison D. Burroughs
`United States District Judge
`
`Dated: December 29, 2022
`
`Respectfully submitted,
`
`/s/ Elaine Herrmann Blais
`Douglas J. Kline (BBO# 556680)
`Elaine Herrmann Blais (BBO# 656142)
`
`/s/ Andrea L. Martin
`Andrea L. Martin (BBO# 666117)
`BURNS & LEVINSON LLP
`
`2
`
`
`
`Case 1:18-cv-12029-ADB Document 637 Filed 12/30/22 Page 3 of 5
`
`Robert Frederickson III (BBO# 670111)
`Molly Grammel (BBO# 688439)
`Joshua S. Weinger (BBO# 690814)
`Alexandra Lu (BBO# 691114)
`Eric T. Romeo (BBO# 691591)
`Kathleen A. McGuinness (BBO# 693760)
`Kevin P. Martin (BBO# 655222)
`Tara R. Thigpen (BBO# 707508)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`dkline@goodwinlaw.com
`eblais@goodwinlaw.com
`rfrederickson@goodwinlaw.com
`mgrammel@goodwinlaw.com
`jweinger@goodwinlaw.com
`alu@goodwinlaw.com
`eromeo@goodwinlaw.com
`kmcguinness@goodwinlaw.com
`kmartin@goodwinlaw.com
`tthigpen@goodwinlaw.com
`
`Natasha E. Daughtrey (pro hac vice)
`Sean M. Anderson (pro hac vice)
`GOODWIN PROCTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`Tel.: (213) 426-2500
`Fax: (213) 623-1673
`ndaughtrey@goodwinlaw.com
`sanderson@goodwinlaw.com
`
`Madeline R. DiLascia (pro hac vice)
`GOODWIN PROCTER LLP
`1900 N Street N.W.
`Washington, D.C. 20036
`Tel.: (202) 346-4000
`Fax: (202) 204-7250
`mdilascia@goodwinlaw.com
`
`Attorneys for Plaintiffs
`
`125 High Street
`Boston, MA 02110-1624
`(617) 345-3000
`amartin@burnslev.com
`Charles E. Lipsey
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`1875 Explorer Street
`Suite 800
`Reston, VA 20190-6023
`Charles.Lipsey@finnegan.com
`Oquinnr@finnegan.com
`
`Emily R. Gabranski (BBO# 694417)
`Marta Garcia Daneshvar
`Lulu Wang (BBO# 704042)
`Li Zhang (BBO# 708499)
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`2 Seaport Lane
`Boston, MA 02210-2001
`Emily.Gabranski@finnegan.com
`Marta.Garcia@finnegan.com
`Lulu.Wang@finnegan.com
`Li.Zhang@finnegan.com
`
`William B. Raich
`Danielle A. Duszczyszyn
`Denise Main
`Pier D. DeRoo
`Matthew Luneack
`Yoonjin Lee
`Sydney R. Kestle
`J. Michael Jakes
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`William.Raich@finnegan.com
`Danielle.Duszczyszyn@finnegan.com
`Denise.Main@finnegan.com
`Pier.DeRoo@finnegan.com
`Matthew.Luneack@finnegan.com
`Yoonjin.Lee@finnegan.com
`Sydney.Kestle@finnegan.com
`
`3
`
`
`
`Case 1:18-cv-12029-ADB Document 637 Filed 12/30/22 Page 4 of 5
`
`Mike.Jakes@finnegan.com
`
`Attorneys for Defendant Eli Lilly and
`Company
`
`
`
`
`
`
`4
`
`
`
`Case 1:18-cv-12029-ADB Document 637 Filed 12/30/22 Page 5 of 5
`
`CERTIFICATE OF SERVICE
`
`I, Elaine Herrmann Blais, hereby certify that a copy of the foregoing document, filed
`
`through the CM/ECF system, will be sent electronically to the registered participants as identified
`
`on the Notice of Electronic Filing ( NEF ) and paper copies shall be served by first class mail
`
`postage prepaid on all counsel of record who are not served through the CM/ECF system on
`
`December 29, 2022.
`
`
`
`/s/ Elaine Herrmann Blais
`Elaine Herrmann Blais (BBO# 656142)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`(617) 570-1000
`eblais@goodwinlaw.com
`
`
`
`5
`
`